Brussels, 18 July 2024 

EuropaBio congratulates Ursula von der Leyen on her re-election for a second mandate as President of the European Commission for the period 2024-2029. We welcome President von der Leyen's continued leadership and her commitment to advancing competitiveness, innovation, and resilience, whilst fostering the biotech revolution to modernise our economies within the European Union.

EuropaBio recalls President von der Leyen’s commitment to presenting an EU Biotech Act in 2025, supporting the Clean Industrial Deal, and the need for simplifying, investing and ensuring access to cheap, sustainable and secure energy supplies and raw materials for industry including biotech (net-zero technology).

Dr Claire Skentelbery, Director General of EuropaBio commented “Biotechnology is rightfully recognised by President von der Leyen as central to Europe’s future. As a critical technology where the EU already has significant scientific and economic strength, we look forward to strong progress and delivery towards the EU ambitions of competitiveness and resilience”. 

EuropaBio looks forward to collaborating with the European Commission and other key stakeholders to deliver an ambitious agenda for the use and applications of biotech in the EU.